SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $653,000 | +10.7% | 69,057 | +4.9% | 0.01% | +16.7% |
Q2 2020 | $590,000 | +40.8% | 65,815 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $419,000 | -24.0% | 65,815 | 0.0% | 0.01% | +20.0% |
Q4 2019 | $551,000 | -7.6% | 65,815 | 0.0% | 0.01% | -16.7% |
Q3 2019 | $596,000 | -15.9% | 65,815 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $709,000 | +12.9% | 65,815 | 0.0% | 0.01% | +20.0% |
Q1 2019 | $628,000 | -37.0% | 65,815 | -24.2% | 0.01% | -44.4% |
Q4 2018 | $997,000 | -58.2% | 86,815 | -38.3% | 0.01% | -43.8% |
Q3 2018 | $2,387,000 | -34.3% | 140,815 | -45.0% | 0.02% | -36.0% |
Q2 2018 | $3,633,000 | +3.5% | 255,815 | +38.5% | 0.02% | 0.0% |
Q1 2018 | $3,509,000 | -35.4% | 184,665 | -44.2% | 0.02% | -30.6% |
Q4 2017 | $5,428,000 | -24.4% | 330,965 | -30.8% | 0.04% | -25.0% |
Q3 2017 | $7,177,000 | +8.6% | 478,465 | -36.3% | 0.05% | +9.1% |
Q2 2017 | $6,610,000 | +69.2% | 751,100 | 0.0% | 0.04% | +69.2% |
Q1 2017 | $3,906,000 | +70.5% | 751,100 | 0.0% | 0.03% | +73.3% |
Q4 2016 | $2,291,000 | -7.7% | 751,100 | +40.1% | 0.02% | -6.2% |
Q3 2016 | $2,482,000 | -6.0% | 536,100 | +17.5% | 0.02% | -5.9% |
Q2 2016 | $2,641,000 | -4.3% | 456,100 | 0.0% | 0.02% | 0.0% |
Q1 2016 | $2,759,000 | -3.2% | 456,100 | +46.1% | 0.02% | 0.0% |
Q4 2015 | $2,849,000 | +138.2% | 312,100 | +47.1% | 0.02% | +183.3% |
Q3 2015 | $1,196,000 | – | 212,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
EMC Capital Management | 61,394 | $460,000 | 0.25% |
Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |